Shah Brijen, Tinsley Andrew, Ullman Thomas
Mount Sinai School of Medicine, New York, NY 10029, USA.
Curr Gastroenterol Rep. 2011 Feb;13(1):87-94. doi: 10.1007/s11894-010-0155-7.
Advances in the treatment of inflammatory bowel disease (IBD) are published routinely in medical journals. Some treatments are sufficiently helpful that their conclusions are incorporated into clinical guidelines. However, such publications and proclamations may go unheeded among practitioners. Underuse, overuse, and misuse of clinical therapeutics, diagnostics, and routine medical processes are sufficiently prevalent among IBD practitioners that movements are afoot to determine the best methods for achieving a minimal uniformity of effective care. Such explorations are part of an effort to improve the quality of care. In this article, we review the background that has led to a push toward quality improvements in medicine in general, in gastroenterology in general, and within IBD specifically.
炎症性肠病（IBD）治疗方面的进展定期发表于医学期刊。有些治疗方法非常有效，其结论已被纳入临床指南。然而，此类出版物和声明在从业者中可能未得到重视。IBD从业者中临床治疗、诊断及常规医疗流程的使用不足、过度使用和误用现象极为普遍，因此人们正在采取行动来确定实现有效护理最低程度一致性的最佳方法。此类探索是提高护理质量努力的一部分。在本文中，我们回顾了推动总体医学、普通胃肠病学以及特定IBD领域质量改进的背景情况。
